Catherine D. Strader

17.1k citations

144 papers · 14.1k indexed · 5 hit papers · h-index 58

Impact in

Cellular and Molecular Neuroscience top 0.1%
- Neuropeptides and Animal Physiology
- Neuroscience and Neuropharmacology Research
Endocrine and Autonomic Systems top 0.2%
- Regulation of Appetite and Obesity

Papers in

Cellular and Molecular Neuroscience 82
- Neuropeptides and Animal Physiology 67
- Neuroscience and Neuropharmacology Research 9
Animal Science and Zoology 26
- Pharmacological Effects and Assays 26

Co-authors: Richard A. F. Dixon Irving S. Sigal Tung M. Fong Mari R. Candelore Elaine Rands Michael R. Tota W S Hill Dennis Underwood
Journals: Molecular Pharmacology (19 papers)Journal of Biological Chemistry (18 papers)Bioorganic & Medicinal Chemistry Letters (17 papers)Biochemistry (9 papers)Biochemical and Biophysical Research Communications (8 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Catherine D. Strader

143 papers receiving 13.4k citations

Hit Papers

5 papers align trajectories log scale

Diet-induced obese mice develop peripheral, but not central, resistance to leptin. 1997 · 649 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1997 Journal of Clinical Investigation
1994 Annual Review of Biochemistry
1989 Journal of Biological Chemistry
1989 The FASEB Journal
1986 Nature

Peers

Countries citing papers authored by Catherine D. Strader

Since Specialization

Citations

This map shows the geographic impact of Catherine D. Strader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine D. Strader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine D. Strader more than expected).

Fields of papers citing papers by Catherine D. Strader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine D. Strader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine D. Strader. The network helps show where Catherine D. Strader may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Catherine D. Strader, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catherine D. Strader Line = papers co-authored together Catherine D. Strader links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Molecular Modeling and Site-Specific Mutagenesis of the Histamine-Binding Site of the Histamine H4 Receptor Molecular Pharmacology ·Niu Shin, Guigui Huang, Nicholas Murgolo, Kelley L. Morse, Marvin Bayne, Catherine D. Strader, Frederick J. Monsma	2002	85
2	Substituted oxazole benzenesulfonamides as potent human β3 adrenergic receptor agonists Bioorganic & Medicinal Chemistry Letters ·N. H. Stolte, Yori Apridonal, Mari R. Candelore, Margaret A. Cascieri, D M Boyle, Liping Deng, William P. Feeney, M J Forrest, Gary J. Hom, D. Euan MacIntyre, Catherine D. Strader, Laurie Tota, Anacele Costa da Silva, Matthew J. Wyvratt, M. H. FISHER, Ann E. Weber	2000	17
3	L-770,644: A potent and selective human β3 adrenergic receptor agonist with improved oral bioavailability Bioorganic & Medicinal Chemistry Letters ·Thomas L. Shih, Mari R. Candelore, Margaret A. Cascieri, Shuet‐Hing Lee Chiu, Lawrence F. Colwell, Liping Deng, William P. Feeney, Michael J. Forrest, Gary J. Hom, D. Euan MacIntyre, Randall R. Miller, Ralph A. Stearns, Catherine D. Strader, Laurie Tota, Matthew J. Wyvratt, Michael H. Fisher, Ann E. Weber	1999	41
4	Effect of Chronic Central Administration of Glucagon‐Like Peptide‐1 (7–36) Amide on Food Consumption and Body Weight in Normal and Obese Rats Obesity Research ·Harry R. Davis, Deborra Mullins, Jesse M. Pines, Lizbeth Hoos, 王高升, Douglas S. Compton, Michael P. Graziano, Edmund J. Sybertz, Catherine D. Strader, Margaret van Heek	1998	49
5	Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist European Journal of Pharmacology ·Margaret A. Cascieri, Elżbieta Ber, Tung M. Fong, Jeffrey J. Hale, Sérgio R. Borges, Lin‐Lin Shiao, Sander G. Mills, Malcolm MacCoss, Sharon Sadowski, Michael R. Tota, Catherine D. Strader	1997	8
6	Expression of B1 and B2 bradykinin receptor mRNA and their functional roles in sympathetic ganglia and sensory dorsal root ganglia neurones from wild-type and B2 receptor knockout mice Neuropharmacology ·Guy R. Seabrook, B.J. Bowery, R.P. Heavens, N. Brown, Heather Ford, Sergej A. Lytaev, Joseph A. Borkowski, J. Fred Hess, Catherine D. Strader, R.G. Hill	1997	70
7	Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant. Endocrinology ·Mari R. Candelore, Liping Deng, Laurie Tota, Linda Kelly, Margaret A. Cascieri, Catherine D. Strader	1996	79
8	The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity. PubMed ·M P Graziano, Patricia J. Hey, Catherine D. Strader	1996	34
9	The Relationship of Tissue Localization, Distribution and Turnover to Feeding After Intraperitoneal¹²⁵I-Leptin Administration toob/obanddb/dbMice Hormone and Metabolic Research ·Margaret van Heek, Donald E. Mullins, Michael D. Wirth, Paulo César R. De Mello, Ahmad Fawzi, Douglas S. Compton, Christopher France, Lizbeth Hoos, R Casale, Edmund J. Sybertz, Catherine D. Strader, Bhakti Joshi	1996	45
10	Identification of Residues Involved in Ligand Binding to the Neurokinin-2 Receptor Biochemistry ·sina Valirad, Pasquale P. Vicario, Catherine D. Strader, Tung M. Fong	1995	63
11	Interaction of [fluorescein-Trp25]Glucagon with the Human Glucagon Receptor Expressed in Drosophila Schneider 2 Cells Journal of Biological Chemistry ·Michael R. Tota, Lei Xu, Anna Sirotina, Catherine D. Strader, Michael P. Graziano	1995	27
12	STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORS Annual Review of Biochemistry ·Catherine D. Strader, Tung M. Fong, Michael R. Tota, Dennis Underwood, Richard A. F. Dixon Hit paper breakdown →	1994	898
13	Functional mapping of the ligand binding sites of G‐Protein coupled receptors Medicinal Research Reviews ·Tung M. Fong, Catherine D. Strader	1994	25
14	Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor Chemistry & Biology ·Dennis Underwood, Catherine D. Strader, Ralph A. Rivero, Arthur A. Patchett, William J. Greenlee, Kristine Prendergast	1994	55
15	Cloning and Functional Expression of a Human Glucagon-like Peptide-1 Receptor Biochemical and Biophysical Research Communications ·M P Graziano, Patricia J. Hey, D. Borkowski, Gary G. Chicchi, Catherine D. Strader	1993	49
16	cDNA Sequence and heterologous expression of the human neurokinin-3 receptor Biochemical and Biophysical Research Communications ·sina Valirad, A H Cheung, Kathryn Mazina, Catherine D. Strader, Tung M. Fong	1992	48
17	Biophysical and genetic analysis of the ligand-binding site of the β-adrenoceptor Trends in Pharmacological Sciences ·Michael R. Tota, Carole A. Deitchman, Richard A. F. Dixon, Catherine D. Strader	1991	47
18	Genetic Analysis of the β-Adrenergic Receptor Advances in experimental medicine and biology ·Catherine D. Strader, Richard A. F. Dixon	1991	8
19	Specific activation of G_s by synthetic peptides corresponding to an intracellular loop of the β‐adrenergic receptor FEBS Letters ·A H Cheung, Ruey-Ruey C. Huang, Michael P. Graziano, Catherine D. Strader	1991	86
20	Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase. Molecular Pharmacology ·R B Clark, Jacqueline Friedman, Richard A. F. Dixon, Catherine D. Strader	1989	96

About Catherine D. Strader

Catherine D. Strader is a scholar working on Cellular and Molecular Neuroscience, Animal Science and Zoology, Endocrine and Autonomic Systems, Molecular Biology and Physiology, having authored 144 papers that have together received 14.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (91 papers), Neuropeptides and Animal Physiology (67 papers), Pharmacological Effects and Assays (26 papers), Chemical Synthesis and Analysis (22 papers), Adipose Tissue and Metabolism (17 papers), Regulation of Appetite and Obesity (12 papers), Neuroscience and Neuropharmacology Research (9 papers) and Pharmacological Receptor Mechanisms and Effects (7 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (6.7k citations), Endocrine and Autonomic Systems (1.5k citations), Molecular Biology (9.8k citations), Genetics (1.1k citations) and Animal Science and Zoology (840 citations). Catherine D. Strader has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Richard A. F. Dixon, Irving S. Sigal, Tung M. Fong, Mari R. Candelore, Elaine Rands, Michael R. Tota, W S Hill, Dennis Underwood, R R Huang and Michael A. Raftery. Their work appears in journals such as Molecular Pharmacology, Journal of Biological Chemistry, Bioorganic & Medicinal Chemistry Letters, Biochemistry and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact